Pharmafile Logo
Pharmafocus logo
Advanced Search

VSV-ZEBOV

Showing 3 posts of 3 posts found.

Ebola virus

Researchers hopeful experimental antiviral treatment stops Ebola

August 26, 2015
Research and Development Ebola, Ebola virus, Ebola virus disease, Toyama Chemical, VSV-ZEBOV, favipiravir, zmapp

An experimental antiviral therapy may have prevented British healthcare workers from contracting Ebola after exposure to the disease in West …

News
Merck image

Merck Ebola vaccine safe and effective in latest trials

April 2, 2015
Research and Development, Sales and Marketing Ebola, Merck, National Institutes of Health, VSV-ZEBOV, Vaccine, Walter Reed Army Institute of Research, newlink

Merck and NewLink’s experimental Ebola vaccine has been found to be safe and effective in a new trial in the …

News
Merck image

Merck Ebola vaccine shows promise

December 4, 2014
Research and Development, Sales and Marketing Ebola, Merck, VSV-ZEBOV, WHO, hug, newlink genetics

Merck and NewLink Genetics’ experimental Ebola vaccine has shown no major side effects in its first trial according to the …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024